Terms ending in 2032
Every in-force patent on Tepha, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,277,986 | Systems and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | |
| US 9,585,744 | Systems and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | |
| US 10,258,460 | Systems and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | |
| US 10,765,507 | Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence | |
| US 8,680,228 | Controlled Hydrolysis of POLY-4-Hydroxybutyrate and Copolymers In force · High confidence | Tepha, Inc. | In force | High confidence | |
| US 9,592,325 | Polymeric, Degradable Drug-Eluting Stents and Coatings In force · High confidence | Tepha, Inc. | In force | High confidence | |
| US 8,858,629 | Systems and Methods for Mastopexy In force · High confidence | Tepha, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.